GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 7
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. James Brent, Md, MD | Anesthesiology | New Albany, IN | $520.16 | $0 |
| Dr. Samantha Campbell, Dnp, Fncp, Aprn, DNP, FNCP, APRN | Family | Tulsa, OK | $519.16 | $0 |
| Mallory Tagge, Aprn-Cnp, Agpcnp-Bc, APRN-CNP, AGPCNP-BC | Nurse Practitioner | Oklahoma City, OK | $513.13 | $0 |
| Tara Draehn, Fnp, FNP | Family | Willis, TX | $508.61 | $0 |
| Renjini Chandra, Md, MD | Physical Medicine & Rehabilitation | Overland Park, KS | $495.84 | $0 |
| Dr. Roxane Bremen, D.o, D.O | Neurology | Kansas City, MO | $479.77 | $0 |
| Dr. Lam Nguyen, Do, DO | Pain Medicine | Tulsa, OK | $455.06 | $0 |
| Mrs. Gwendolynn Thomas, Aprn, APRN | Family | Elizabethtown, KY | $453.83 | $0 |
| Shannon Morgenstern, Np, NP | Nurse Practitioner | Tucson, AZ | $453.19 | $0 |
| John Wrightson, Md, MD | Sports Medicine | New Castle, PA | $449.19 | $0 |
| Dr. Gerard Limerick, Md, MD | Anesthesiology | Baltimore, MD | $447.92 | $0 |
| Dr. John Prunskis, Md, MD | Interventional Pain Medicine | Elgin, IL | $444.00 | $0 |
| Dr. Natalie Strickland, Natalie Strickland, NATALIE STRICKLAND | Anesthesiology | Fort Smith, AR | $441.27 | $0 |
| Dr. Chad Pletnick, Md, MD | Anesthesiology | Oro Valley, AZ | $435.03 | $0 |
| Shelley Vanhoozer, Aprn, APRN | Nurse Practitioner | Omaha, NE | $431.47 | $0 |
| Mr. Son Le, Md, MD | Physical Medicine & Rehabilitation | Mt. Juliet, TN | $426.26 | $0 |
| Dr. Philip Otterbeck, M.d, M.D | Endocrinology, Diabetes & Metabolism | Staten Island, NY | $424.97 | $0 |
| Dr. Thomas Zwick, D.p.m, D.P.M | Foot & Ankle Surgery | Miami, FL | $418.52 | $0 |
| Dr. Timothy Greene, Dpm, DPM | Foot & Ankle Surgery | Murrieta, CA | $417.06 | $0 |
| Vipul Desai, Md, MD | Infectious Disease | The Woodlands, TX | $415.75 | $0 |
| Michael Fein, Dpm, DPM | Podiatrist | Bethel, CT | $408.64 | $0 |
| Joseph Mouhanna, Md, MD | Pain Medicine | South Miami, FL | $407.29 | $0 |
| Mrs. Ashley Homan, Arnp, ARNP | Registered Nurse | Omaha, NE | $406.33 | $0 |
| Dr. Kevin Balter, Md, MD | Pain Medicine | Omaha, NE | $405.99 | $0 |
| Dr. Daniel Talamo, Do, DO | Family Medicine | Santa Clara, CA | $400.12 | $0 |
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.